Video: Case Dismissed! Texas Ends 15-Year Fight Against Cancer Doctor Burzynski

Video Case Dismissed Texas Ends 15-Year Fight Against Cancer Doctor Burzynski
Video Case Dismissed Texas Ends 15-Year Fight Against Cancer Doctor Burzynski

After a grueling 15-year long battle, the Texas Medical Board has officially ended its crusade to revoke Dr. Stanislaw Burzynski‘s medical license in an effort to end his use of Antineoplastons, as well as his combination gene-targeted therapy for cancer.

The Texas Medical Board’s case against him was dismissed1 on November 19, 2012, just in time for Thanksgiving. According to Dr. Burzynski’s attorney, Richard A. Jaffe, Esq:2

“Early on, two medical board informal settlement panels found that the use of these combination drugs on the advanced cancer patients involved was within the standard of care.

However, the Texas Medical Board refused to drop the case and instead filed a formal complaint3 against Dr. Burzynski alleging the same standard of care violations previously rejected by the board settlement panels.

012. However, a week before trial, the administrative law judges dismissed most of the charges against Dr. Burzynski which forced the Board to seek to adjourn the case to do some reevaluation.

After the judges denied the Board’s attempt to reverse the previous partial dismissal of the case, the Board did more reevaluation and moved to dismiss the entire case.”

In 2010, Texas Medical Board staff charged4 Dr. Burzynski with prescribing and administering drugs not yet approved by the FDA for the treatment of cancer in two patients. They also claimed he had overcharged for the drugs, and, in one case, that he had failed to inform the patient that the treatment was having an insignificant impact on her cancer, delaying her ability to make an informed decision about whether to continue her treatment.

On both counts, the Board determined that the treatments did not violate the standard of care, and that patients had been appropriately billed. They did however agree he failed to inform the patient that the treatment was ineffective, and in the other case, they determined he had failed to maintain adequate medical records.

Dr. Burzynski to Make History Yet Again

Dr. Burzynski received much-needed publicity two years ago with the release of Burzynski — The Movie, a documentary about Dr. Burzynski’s remarkable cancer discovery, and how he won the largest and possibly the most convoluted and intriguing legal battle against the Food and Drug Administration (FDA) in American history.

This year, a second film detailing his continued struggles, and victories, is scheduled to be released. As announced in the trailer (see above), Dr. Burzynski is now doing the unthinkable… He is “the first and only scientist in United States history to enter the federal drug approval process for a proprietary cancer therapy without any financial support from the American government, the pharmaceutical industry, or the cancer establishment.”

After it was revealed that the FDA had pressured the Texas medical board to revoke Dr. Burzynski’s medical license — despite the fact that no laws were broken, and his treatment was proven safe and effective — the obvious question was“why?” In1982, Dr. Richard Crout, Director of the FDA Bureau of Drugs, wrote:

“I never have and never will approve a new drug to an individual, but only to a large pharmaceutical firm with unlimited finances.”

The answer to this has to do with money. Lots and lots of money… See, Dr. Burzynski owns the patent for this treatment, and should it actually gain FDA approval, not only would it threaten conventional chemotherapy and radiation, it would also result in billions of dollars of cancer research funds being funneled over to the one single scientist who has exclusive patent rights — Dr. Burzynski.

When Medical Harassment Becomes Standard Practice

As Burzynski — The Movie revealed, it became clear that ever since 1977, when Dr. Burzynski first tried to get antineoplastons approved, the FDA had begun scheming to eliminate the threat he and his discovery posed to the cancer industry. With that in mind, the mistreatment dished out by the Texas Medical Board (TMB) against Dr. Burzynski becomes easier to understand.

The situation becomes even more enlightening once you take into account the fact that, for years, the TMB has cultivated intimidation and harassment of doctors to the point that the entire Board was sued by the Association of American Physicians and Surgeons (AAPS) in 2007, citing an “institutional culture of retaliation and intimidation.” The suit specifically pointed out misconduct by then Board president, Roberta Kalafut, who was accused of enlisting her husband to file anonymous complaints against targeted doctors, including her own competitors, who then faced losing their license and other punitive disciplinary actions based on fraudulent charges. (She resigned from her post in December 2008.)5

The situation was so bad that legislation was drafted in 2009 in an effort to clamp down on the abuses by the TMB.6 Unfortunately, the bill, HB3816, failed to get a House vote and didn’t make it into law. The bill would have prevented anonymous, unsworn complaints from ruining the careers of doctors, and given physicians a right to jury trial before license revocation, among other things. It seems not much has changed in the years since. In an AAPS blog dated September 22, 2011, Jane M. Orient, MD, Executive Director of AAPS stated:7

“Complaints from our members have identified the TMB as probably the worst in the country. It’s bad for patients when their doctors are afraid that doing the right thing could result in licensure action.”

Summary of Dr. Burzynski’s Cancer Treatment

Dr. Stanislaw Burzynski, a Polish immigrant, was trained as both a biochemist and a physician. He’s spent the last 35 years developing and successfully treating cancer patients suffering with some of the most lethal forms of cancer at his clinic in Houston, Texas. The treatment he developed involves a gene-targeted approach using non-toxic peptides and amino acids, known as antineoplastons. I personally interviewed Dr. Burzynski about his treatment in the summer of 2011.